Expertise in
5
conditions

Thomas A. Lutz

Zurich, ZH, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Zurich, ZH, CH 

Overview

Thomas Lutz practices practicing medicine in Zurich, Switzerland.

Mr. Lutz is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Obesity, Cerebral Hypoxia, Acute Mountain Sickness, Gastric Bypass, and Oophorectomy.

He is actively involved in clinical research, co-authoring 193 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Zurich, ZH, Switzerland
Other Locations
Niederweningen / Niederweningen (dorf), ZH 8166, Switzerland
Liestal, BL, Switzerland
Schlieren, ZH, Switzerland
Bern, BE, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
View 1 Less Clinical Trial

193 Total Publications

Amylin: A Multi-Functional Pancreatic Hormone-A Review.
Amylin: A Multi-Functional Pancreatic Hormone-A Review.
Journal: Diabetes, obesity & metabolism
Published: June 11, 2026

Frequently Asked Questions about Thomas A. Lutz

Is Thomas A. Lutz a top-rated expert for Gastric Bypass?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas A. Lutz is classified as an Elite expert for Gastric Bypass, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas A. Lutz participate in research or clinical trials?

Yes. Thomas A. Lutz has published 193 articles and abstracts on conditions like Gastric Bypass. You can view a list of Thomas A. Lutz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lutz's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile